Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure.

Kentsch, M; Otter, W; Drummer, C; Nötges, A; Gerzer, R; Müller-Esch, G

Kentsch, M; Otter, W; Drummer, C; Nötges, A; Gerzer, R; Müller-Esch, G.

Affiliation

Kentsch M; Department of Internal Medicine, Hansestadt Stralsund, Germany.

Eur J Clin Pharmacol ; 51(3-4): 269-72, 1996.

Article in En | MEDLINE | ID: mdl-9010697

Subject(s)

Heart Failure/drug therapy; Hemodynamics/drug effects; Indans/therapeutic use; Neprilysin/antagonists & inhibitors; Propionates/therapeutic use; Protease Inhibitors/therapeutic use; Aldosterone/blood; Atrial Natriuretic Factor/blood; Cyclic AMP/analysis; Double-Blind Method; Heart Failure/physiopathology; Humans; Indans/pharmacology; Middle Aged; Propionates/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Protease Inhibitors / Neprilysin / Heart Failure / Hemodynamics / Indans Type of study: Clinical_trials Limits: Humans / Middle aged Language: En Journal: Eur J Clin Pharmacol Year: 1996 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links